Steven Cohen Applied Therapeutics Inc. Transaction History

Point72 Asset Management, L.P.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.77 - $1.8 $188,656 - $441,016	-245,009 Reduced 34.03%	474,929 $607,000
Q4 2022 Feb 14, 2023	SELL	$0.54 - $1.12 $540,000 - $1.12 Million	-1,000,000 Reduced 58.14%	719,938 $547,000
Q3 2022 Nov 14, 2022	SELL	$0.86 - $1.55 $958,953 - $1.73 Million	-1,115,062 Reduced 39.33%	1,719,938 $1.6 Million
Q2 2022 Aug 15, 2022	BUY	$0.76 - $2.64 $217,360 - $755,040	286,000 Added 11.22%	2,835,000 $2.69 Million
Q1 2022 May 16, 2022	BUY	$1.48 - $6.22 $2.12 Million - $8.93 Million	1,435,000 Added 128.82%	2,549,000 $5.38 Million
Q4 2021 Feb 14, 2022	BUY	$8.77 - $18.29 $865,853 - $1.81 Million	98,729 Added 9.72%	1,114,000 $9.97 Million
Q3 2021 Nov 15, 2021	BUY	$13.54 - $22.06 $7.08 Million - $11.5 Million	522,771 Added 106.15%	1,015,271 $16.9 Million
Q2 2021 Aug 16, 2021	BUY	$14.05 - $25.04 $2.73 Million - $4.86 Million	194,200 Added 65.1%	492,500 $10.2 Million
Q1 2021 May 17, 2021	BUY	$16.57 - $28.65 $2.29 Million - $3.96 Million	138,300 Added 86.44%	298,300 $5.6 Million
Q4 2020 Feb 16, 2021	BUY	$15.44 - $24.23 $592,679 - $930,092	38,386 Added 31.56%	160,000 $3.52 Million
Q3 2020 Nov 16, 2020	SELL	$19.43 - $35.36 $2.08 Million - $3.79 Million	-107,110 Reduced 46.83%	121,614 $2.53 Million
Q2 2020 Aug 14, 2020	SELL	$29.41 - $51.23 $8.85 Million - $15.4 Million	-300,750 Reduced 56.8%	228,724 $8.27 Million
Q1 2020 May 15, 2020	BUY	$19.54 - $55.47 $10.3 Million - $29.4 Million	529,474 New	529,474 $17.3 Million

140

112M

1.68M

1.91M

Ticker APLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,700
Market Cap $442M
Description
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.